Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 386, Issue 24, Pages 2340-2342Publisher
MASSACHUSETTS MEDICAL SOC
DOI: 10.1056/NEJMc2205019
Keywords
-
Categories
Funding
- National Cancer Institute of the National Institutes of Health (NIH) [U54CA260582]
- NIH [R01 AI150473, R01 HD095881]
- Glenn Barber Fel-lowship from the Ohio State University College of Veterinary Medicine [UL1TR002733, KL2TR002734]
- Robert J. Anthony Fund for Cardiovascular Research
- JB Cardio-vascular Research Fund
- National Center for Advancing Trans-lational Sciences
Ask authors/readers for more resources
The study found that the Delta variant has high resistance to immune responses elicited by vaccines or previous infections, while the BA.3 variant does not show broad cross-resistance.
Neutralization of Deltacron and BA.3 SARS-CoV-2 Variants A small study assessed the neutralization of pseudoviruses composed of the recombinant deltacron and omicron BA.3 variants. BA.3 did not show broad cross-resistance, but deltacron was largely resistant to immune response elicited either by three doses of mRNA vaccines or by previous infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
